APA (7th ed.) Citation

D, L., J, S., J, G., D, P., R, G., L, D. B., . . . A, N. (2021). Safety/Efficacy of DOAC Versus Aspirin for Reduction of Risk of Cerebrovascular Events Following VT Ablation. JACC. Clinical electrophysiology, 7(12), 1493. https://doi.org/10.1016/j.jacep.2021.07.010

Chicago Style (17th ed.) Citation

D, Lakkireddy, et al. "Safety/Efficacy of DOAC Versus Aspirin for Reduction of Risk of Cerebrovascular Events Following VT Ablation." JACC. Clinical Electrophysiology 7, no. 12 (2021): 1493. https://doi.org/10.1016/j.jacep.2021.07.010.

MLA (9th ed.) Citation

D, Lakkireddy, et al. "Safety/Efficacy of DOAC Versus Aspirin for Reduction of Risk of Cerebrovascular Events Following VT Ablation." JACC. Clinical Electrophysiology, vol. 7, no. 12, 2021, p. 1493, https://doi.org/10.1016/j.jacep.2021.07.010.